Literature DB >> 27384661

Genetic Lineage and Reassortment of Influenza C Viruses Circulating between 1947 and 2014.

Yoko Matsuzaki1, Kanetsu Sugawara2, Yuki Furuse3, Yoshitaka Shimotai2, Seiji Hongo2, Hitoshi Oshitani3, Katsumi Mizuta4, Hidekazu Nishimura5.   

Abstract

Since influenza C virus was first isolated in 1947, the virus has been only occasionally isolated by cell culture; there are only four strains for which complete genome sequences are registered. Here, we analyzed a total of 106 complete genomes, ranging from the first isolate from 1947 to recent isolates from 2014, to determine the genetic lineages of influenza C virus, the reassortment events, and the rates of nucleotide substitution. The results showed that there are six lineages, named C/Taylor, C/Mississippi, C/Aichi, C/Yamagata, C/Kanagawa, and C/Sao Paulo. They contain both antigenic and genetic lineages of the hemagglutinin-esterase (HE) gene, and the internal genes PB2, PB1, P3, NP, M, and NS are divided into two major lineages, a C/Mississippi/80-related lineage and a C/Yamagata/81-related lineage. Reassortment events were found over the entire period of 68 years. Several outbreaks of influenza C virus between 1990 and 2014 in Japan consisted of reassortant viruses, suggesting that the genomic constellation is related to influenza C virus epidemics. The nucleotide sequences were highly homologous to each other. The minimum percent identity between viruses ranged from 91.1% for the HE gene to 96.1% for the M gene, and the rate of nucleotide substitution for the HE gene was the highest, at 5.20 × 10(-4) substitutions/site/year. These results indicate that reassortment is an important factor that increases the genetic diversity of influenza C virus, resulting in its ability to prevail in humans. IMPORTANCE Influenza C virus is a pathogen that causes acute respiratory illness in children and results in hospitalization of infants. We previously demonstrated (Y. Matsuzaki et al., J Clin Virol 61:87-93, 2014, http://dx.doi.org/10.1016/j.jcv.2014.06.017) that periodic epidemics of this virus occurred in Japan between 1996 and 2014 and that replacement of the dominant antigenic group occurred every several years as a result of selection by herd immunity. However, the antigenicity of the HE glycoprotein is highly stable, and antigenic drift has not occurred for at least 30 years. Here, we analyzed a total of 106 complete genomes spanning 68 years for the first time, and we found that influenza C viruses are circulating worldwide while undergoing reassortment as well as selection by herd immunity, resulting in an increased ability to prevail in humans. The results presented in this study contribute to the understanding of the evolution, including reassortment events, underlying influenza C virus epidemics.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27384661      PMCID: PMC5008092          DOI: 10.1128/JVI.00969-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The dominant antigenic group of influenza C infections changed from c/Sao Paulo/378/82-lineage to c/Kanagawa/1/76-lineage in Yamagata, Japan, in 2014.

Authors:  Shizuka Tanaka; Yoko Aoki; Yohei Matoba; Kazue Yahagi; Katsumi Mizuta; Tsutomu Itagaki; Fumio Katsushima; Yuriko Katsushima; Yoko Matsuzaki
Journal:  Jpn J Infect Dis       Date:  2015       Impact factor: 1.362

2.  Phylogenetic analysis of influenza C virus nonstructural (NS) protein genes and identification of the NS2 protein.

Authors:  A S M Alamgir; Yoko Matsuzaki; Seiji Hongo; Emi Tsuchiya; Kanetsu Sugawara; Yasushi Muraki; Kiyoto Nakamura
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

3.  Cocirculation of two distinct groups of influenza C virus in Yamagata City, Japan.

Authors:  Y Matsuzaki; Y Muraki; K Sugawara; S Hongo; H Nishimura; F Kitame; N Katsushima; Y Numazaki; K Nakamura
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

4.  Isolation of influenza C virus from pigs and experimental infection of pigs with influenza C virus.

Authors:  Y J Guo; F G Jin; P Wang; M Wang; J M Zhu
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

5.  Evolution of the haemagglutinin-esterase gene of influenza C virus.

Authors:  Y Muraki; S Hongo; K Sugawara; F Kitame; K Nakamura
Journal:  J Gen Virol       Date:  1996-04       Impact factor: 3.891

6.  Clinical features of influenza C virus infection in children.

Authors:  Yoko Matsuzaki; Noriko Katsushima; Yukio Nagai; Makoto Shoji; Tsutomu Itagaki; Michiyo Sakamoto; Setsuko Kitaoka; Katsumi Mizuta; Hidekazu Nishimura
Journal:  J Infect Dis       Date:  2006-03-31       Impact factor: 5.226

7.  Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Emi Takashita; Yasushi Muraki; Seiji Hongo; Noriko Katsushima; Katsumi Mizuta; Hidekazu Nishimura
Journal:  J Med Virol       Date:  2004-09       Impact factor: 2.327

8.  Human antibody to influenza C virus: its age-related distribution and distinction from receptor analogs.

Authors:  R J O'Callaghan; R S Gohd; D D Labat
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein.

Authors:  Yasushi Muraki; Toshio Murata; Emi Takashita; Yoko Matsuzaki; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

10.  Influenza C virus infection in France.

Authors:  J C Manuguerra; C Hannoun; M Aymard
Journal:  J Infect       Date:  1992-01       Impact factor: 6.072

View more
  24 in total

1.  The Extended C-Terminal Region of Influenza C Virus Nucleoprotein Is Important for Nuclear Import and Ribonucleoprotein Activity.

Authors:  Yun-Sang Tang; Chun-Yeung Lo; Chris Ka-Pun Mok; Paul Kay-Sheung Chan; Pang-Chui Shaw
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

2.  Effect of Phosphorylation of CM2 Protein on Influenza C Virus Replication.

Authors:  Takanari Goto; Yoshitaka Shimotai; Yoko Matsuzaki; Yasushi Muraki; Ri Sho; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

3.  TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.

Authors:  Ko Sato; Hideki Hayashi; Yoshitaka Shimotai; Mutsuo Yamaya; Seiji Hongo; Kazuyoshi Kawakami; Yoko Matsuzaki; Hidekazu Nishimura
Journal:  J Virol       Date:  2021-08-18       Impact factor: 5.103

4.  Generation, Characterization, and Applications of Influenza A Reporter Viruses.

Authors:  Kevin Chiem; Aitor Nogales; Luis Martinez-Sobrido
Journal:  Methods Mol Biol       Date:  2022

5.  An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice.

Authors:  Yongzhen Zhao; Lingcai Zhao; Yingfei Li; Qingzheng Liu; Lulu Deng; Yuanlu Lu; Xiaoting Zhang; Shengmin Li; Jinying Ge; Zhigao Bu; Jihui Ping
Journal:  Vet Microbiol       Date:  2022-06-09       Impact factor: 3.246

6.  Genetic and antigenic characteristics of a human influenza C virus clinical isolate.

Authors:  Runxia Liu; Zizhang Sheng; Tao Lin; Chithra Sreenivasan; Rongruan Gao; Milton Thomas; Julian Druce; Ben M Hause; Radhey S Kaushik; Feng Li; Dan Wang
Journal:  J Med Virol       Date:  2019-09-23       Impact factor: 2.327

Review 7.  Influenza.

Authors:  Sam Ghebrehewet; Peter MacPherson; Antonia Ho
Journal:  BMJ       Date:  2016-12-07

8.  Analyses of Evolutionary Characteristics of the Hemagglutinin-Esterase Gene of Influenza C Virus during a Period of 68 Years Reveals Evolutionary Patterns Different from Influenza A and B Viruses.

Authors:  Yuki Furuse; Yoko Matsuzaki; Hidekazu Nishimura; Hitoshi Oshitani
Journal:  Viruses       Date:  2016-11-26       Impact factor: 5.048

9.  Influenza C in Lancaster, UK, in the winter of 2014-2015.

Authors:  Kate V Atkinson; Lisa A Bishop; Glenn Rhodes; Nicolas Salez; Neil R McEwan; Matthew J Hegarty; Julie Robey; Nicola Harding; Simon Wetherell; Robert M Lauder; Roger W Pickup; Mark Wilkinson; Derek Gatherer
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

Review 10.  Substantial effect of phytochemical constituents against the pandemic disease influenza-a review.

Authors:  A Brindha Devi; R Sarala
Journal:  Futur J Pharm Sci       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.